MULTIPLE MYELOMA (MM) REFRACTORY TO LENALIDOMIDE: A SYSTEMATIC LITERATURE REVIEW (SLR) OF RANDOMISED CONTROLLED TRIALS (RCTS)

被引：0
|
作者：
McNamara, S. [1 ]
Kazeem, G. [1 ]
Carter, J. A. [2 ]
Bitetti, J. [3 ]
Wang, P. F. [4 ]
机构：
[1] GSK, Stevenage, Herts, England
[2] Open Hlth, Bethesda, MD USA
[3] GSK, Zug, Switzerland
[4] GSK, Collegeville, PA USA
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
CO101
引用
收藏
页码：S33 / S33
页数：1
相关论文
共 50 条
  • [21] Review of therapy for relapsed/refractory multiple myeloma: focus on lenalidomide
    Mariz, Jose Mario
    Esteves, Graca Vasconcelos
    CURRENT OPINION IN ONCOLOGY, 2012, 24 : S3 - S12
  • [22] Attrition and withdrawal in multiple myeloma randomized controlled trials: A systematic review
    Hentzen, Stijn
    Meirson, Tomer
    Koehn, Kelly
    Goodman, Aaron
    Chakraborty, Rajshekhar
    Sborov, Douglas
    Rubinstein, Samuel
    Mohyuddin, Ghulam Rehman
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2023, 111 (03) : 491 - 498
  • [23] Enhanced Recovery after Surgery (ERAS): a Systematic Review of Randomised Controlled Trials (RCTs) in Bariatric Surgery
    Parisi, Amilcare
    Desiderio, Jacopo
    Cirocchi, Roberto
    Trastulli, Stefano
    OBESITY SURGERY, 2020, 30 (12) : 5071 - 5085
  • [24] Enhanced Recovery after Surgery (ERAS): a Systematic Review of Randomised Controlled Trials (RCTs) in Bariatric Surgery
    Amilcare Parisi
    Jacopo Desiderio
    Roberto Cirocchi
    Stefano Trastulli
    Obesity Surgery, 2020, 30 : 5071 - 5085
  • [25] ECONOMIC AND SOCIAL BURDEN OF RELAPSED OR REFRACTORY MULTIPLE MYELOMA: A SYSTEMATIC REVIEW OF THE LITERATURE
    Casado, L. F.
    Rubio-Rodriguez, D.
    Dias Ferreira, C.
    VALUE IN HEALTH, 2018, 21 : S448 - S448
  • [26] Pomalidomide, Bortezomib and Dexamethasone (PVD) for Patients with Relapsed Lenalidomide Refractory Multiple Myeloma (MM)
    Lacy, Martha Q.
    LaPlant, Betsy R.
    Laumann, Kristina M.
    Kumar, Shaji
    Gertz, Morie A.
    Hayman, Suzanne R.
    Buadi, Francis
    Dispenzieri, Angela
    Lust, John A.
    Kapoor, Prashant
    Leung, Nelson
    Russell, Stephen J.
    Dingli, David
    Gonsalves, Wilson I.
    Fonseca, Rafael
    Bergsagel, P. Leif
    Roy, Vivek
    Sher, Taimur
    Ailawadhi, Sikander
    Chanan-Khan, Asher
    Stewart, A. Keith
    Reeder, Craig B.
    Rajkumar, S. Vincent
    Mikhael, Joseph R.
    BLOOD, 2014, 124 (21)
  • [27] THE DEFINITION OF A HEMODYNAMIC SIGNIFICANT DUCT IN RANDOMISED CONTROLLED TRIALS, A SYSTEMATIC LITERATURE REVIEW
    Zonnenberg, I.
    de Waal, K.
    PEDIATRIC RESEARCH, 2010, 68 : 116 - 117
  • [28] Quality of control groups in randomised trials of multiple myeloma enrolling in the USA: a systematic review
    Mohyuddin, Ghulam Rehman
    Koehn, Kelly
    Sborov, Douglas
    McClune, Brian
    Abdallah, Al-Ola
    Goodman, Aaron M.
    Prasad, Vinay
    LANCET HAEMATOLOGY, 2021, 8 (04): : E299 - E304
  • [29] Lenalidomide A Review of its Use in the Treatment of Relapsed or Refractory Multiple Myeloma
    Scott, Lesley J.
    Lyseng-Williamson, Katherine A.
    DRUGS, 2011, 71 (05) : 625 - 649
  • [30] Thromboprophylaxis in multiple myeloma patients treated with lenalidomide - A systematic review
    Al-Ani, Fatimah
    Bastida Bermejo, Jose Maria
    Mateos, Maria-Victoria
    Louzada, Martha
    THROMBOSIS RESEARCH, 2016, 141 : 84 - 90
12345